CN Stock MarketDetailed Quotes

300142 Walvax Biotechnology

Watchlist
  • 11.44
  • +0.05+0.44%
Market Closed Aug 2 15:00 CST
18.37BMarket Cap70.18P/E (TTM)

Walvax Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-28.02%599.75M
-19.12%4.11B
-14.79%3.16B
-7.68%2.17B
27.04%833.27M
46.89%5.09B
74.06%3.71B
73.96%2.35B
51.27%655.89M
17.82%3.46B
Operating revenue
-28.02%599.75M
-19.12%4.11B
-14.79%3.16B
-7.68%2.17B
27.04%833.27M
46.89%5.09B
74.06%3.71B
73.96%2.35B
51.27%655.89M
17.82%3.46B
Other operating revenue
----
3.51%7.92M
----
-40.96%3.3M
----
-27.15%7.65M
----
8.83%5.6M
----
-9.68%10.5M
Total operating cost
-30.14%462.15M
-17.18%3.15B
-15.59%2.32B
-9.79%1.53B
27.85%661.54M
44.85%3.81B
76.83%2.75B
72.20%1.69B
62.05%517.42M
37.38%2.63B
Operating cost
-9.07%113.52M
-1.95%597.56M
3.88%451.26M
-6.92%272.57M
64.36%124.85M
54.55%609.47M
60.86%434.39M
76.23%292.83M
39.37%75.96M
-1.37%394.34M
Operating tax surcharges
-64.08%4.17M
-3.68%32.03M
1.09%25.37M
50.32%19.71M
134.35%11.62M
67.71%33.25M
96.91%25.1M
60.98%13.11M
53.10%4.96M
14.10%19.83M
Operating expense
-31.01%210.46M
-24.85%1.52B
-22.78%1.14B
-13.33%783.05M
18.70%305.03M
51.93%2.02B
94.64%1.48B
80.97%903.5M
63.57%256.98M
17.77%1.33B
Administration expense
6.10%61.79M
9.65%297.62M
-2.72%180.63M
6.17%120.9M
6.59%58.23M
-9.44%271.42M
-8.10%185.68M
-17.15%113.87M
-9.89%54.63M
36.54%299.71M
Financial expense
13.44%-14.8M
-12.72%-70.99M
1.10%-53.19M
-10.75%-35.26M
-20.32%-17.1M
-62.65%-62.98M
-105.73%-53.78M
-98.79%-31.84M
-83.26%-14.21M
-26.14%-38.72M
-Interest expense (Financial expense)
164.41%3.38M
-16.30%5.95M
-31.83%3.76M
-26.11%2.72M
-57.67%1.28M
23.15%7.11M
38.49%5.51M
58.42%3.69M
211.10%3.02M
865.92%5.77M
-Interest Income (Financial expense)
-3.64%-18.31M
-6.01%-74.23M
-2.19%-52.66M
-5.98%-36.26M
-3.47%-17.67M
-54.19%-70.03M
-70.35%-51.53M
-83.52%-34.21M
-92.61%-17.08M
-21.34%-45.42M
Research and development
-51.36%87.02M
-16.77%776.43M
-15.34%573.44M
-8.77%365.19M
28.61%178.91M
50.11%932.89M
101.94%677.34M
113.50%400.31M
169.71%139.11M
252.13%621.49M
Credit Impairment Loss
-1,402.83%-9.89M
-92.81%-88.52M
-186,850.31%-67.08M
-1,587.95%-60.68M
-254.44%-658.31K
-216.11%-45.91M
99.76%-35.88K
575.49%4.08M
-91.08%426.26K
-11.99%39.54M
Asset Impairment Loss
-8.55%-7.61M
-164.60%-162.64M
57.44%-12.57M
71.30%-3.59M
-870.11%-7.01M
-418.91%-61.47M
-423.77%-29.54M
-19.10%-12.51M
78.89%-722.31K
-140.82%-11.85M
Other net revenue
-282.35%-77.95M
-92.27%-347.59M
54.69%-57.86M
76.38%-9.47M
193.47%42.75M
-44.72%-180.78M
-1,086.84%-127.72M
-140.44%-40.1M
-135.75%-45.74M
-135.70%-124.92M
Fair value change income
-7,010.23%-84.82M
-17.77%-234.75M
68.31%-67.39M
75.39%-17.65M
98.52%-1.19M
29.00%-199.33M
-125.78%-212.64M
-511.82%-71.73M
-181.58%-80.36M
-200.30%-280.74M
Invest income
132.44%86.84K
-39.69%7.11M
30.18%6.29M
1,266.22%6.33M
-76.86%-267.7K
-79.62%11.8M
-91.68%4.84M
-100.93%-542.64K
72.95%-151.36K
971.88%57.88M
-Including: Investment income associates
140.26%86.84K
135.58%382.09K
34.76%-437.76K
25.55%-404.02K
-42.50%-215.69K
-15.18%-1.07M
7.70%-670.98K
-38.60%-542.64K
72.95%-151.36K
-615.85%-932.43K
Asset deal income
----
-116.55%-827.73K
-1,703.04%-574.86K
--172.21K
--172.21K
-265.55%-382.24K
-116.58%-31.88K
----
----
121.47%230.88K
Other revenue
-53.05%24.28M
15.30%132.03M
-23.91%83.46M
62.40%65.95M
47.44%51.7M
63.55%114.51M
141.19%109.69M
23.01%40.61M
330.53%35.07M
172.28%70.02M
Operating profit
-72.19%59.65M
-44.16%613.97M
-6.00%779.31M
2.58%632.06M
131.30%214.48M
54.79%1.1B
47.10%829.07M
32.11%616.16M
-2.27%92.73M
-48.39%710.28M
Add:Non operating Income
-99.79%101.88
619.41%935.06K
1,413.66%933.18K
1,242.62%913.18K
231.12%48.85K
-95.02%129.98K
-97.13%61.65K
-96.78%68.02K
-99.16%14.75K
-63.53%2.61M
Less:Non operating expense
-36.87%2.4M
-45.28%15.92M
-74.18%6.02M
-70.10%4.94M
-58.74%3.8M
638.26%29.1M
694.08%23.33M
452.91%16.54M
318.56%9.2M
-61.12%3.94M
Total profit
-72.83%57.25M
-44.05%598.98M
-3.92%774.22M
4.72%628.02M
152.24%210.73M
50.99%1.07B
43.17%805.8M
28.82%599.7M
-11.54%83.54M
-48.38%708.95M
Less:Income tax cost
52.41%18.94M
-33.72%87.65M
-34.25%76.99M
-32.99%65.47M
-26.00%12.43M
22.91%132.24M
49.40%117.1M
68.46%97.7M
-1.66%16.79M
-33.63%107.59M
Net profit
-80.68%38.31M
-45.50%511.33M
1.24%697.23M
12.06%562.55M
197.09%198.3M
56.02%938.23M
42.16%688.7M
23.17%501.99M
-13.72%66.75M
-50.35%601.35M
Net profit from continuing operation
-80.68%38.31M
-45.50%511.33M
1.24%697.23M
12.06%562.55M
197.09%198.3M
56.02%938.23M
42.16%688.7M
23.17%501.99M
-13.72%66.75M
-50.35%601.35M
Less:Minority Profit
-8.09%24.18M
-56.13%91.93M
-8.55%143.85M
32.50%107.31M
-6.45%26.31M
20.72%209.57M
31.00%157.31M
-8.34%80.99M
-37.78%28.13M
-16.54%173.6M
Net profit of parent company owners
-91.79%14.13M
-42.44%419.39M
4.14%553.38M
8.13%455.24M
345.34%171.99M
70.35%728.65M
45.84%531.39M
31.90%421.01M
20.09%38.62M
-57.36%427.75M
Earning per share
Basic earning per share
-91.81%0.0088
-42.34%0.2621
2.40%0.3458
8.18%0.2844
345.64%0.1074
66.70%0.4546
44.69%0.3377
28.37%0.2629
16.43%0.0241
-58.16%0.2727
Diluted earning per share
-91.81%0.0088
-42.32%0.2621
2.49%0.3458
8.38%0.2844
345.64%0.1074
67.12%0.4544
45.62%0.3374
30.16%0.2624
16.99%0.0241
-57.74%0.2719
Other composite income
-96.66%850K
-86.67%25.45M
Other composite income of parent company owners
----
----
----
----
----
-96.66%850K
----
----
----
-86.67%25.45M
Total composite income
-80.68%38.31M
-45.55%511.33M
1.24%697.23M
12.06%562.55M
197.09%198.3M
49.82%939.08M
42.16%688.7M
23.17%501.99M
-13.72%66.75M
-55.29%626.8M
Total composite income of parent company owners
-91.79%14.13M
-42.51%419.39M
4.14%553.38M
8.13%455.24M
345.34%171.99M
60.97%729.5M
45.84%531.39M
31.90%421.01M
20.09%38.62M
-62.05%453.2M
Total composite income of minority owners
-8.09%24.18M
-56.13%91.93M
-8.55%143.85M
32.50%107.31M
-6.45%26.31M
20.72%209.57M
31.00%157.31M
-8.34%80.99M
-37.78%28.13M
-16.54%173.6M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -28.02%599.75M-19.12%4.11B-14.79%3.16B-7.68%2.17B27.04%833.27M46.89%5.09B74.06%3.71B73.96%2.35B51.27%655.89M17.82%3.46B
Operating revenue -28.02%599.75M-19.12%4.11B-14.79%3.16B-7.68%2.17B27.04%833.27M46.89%5.09B74.06%3.71B73.96%2.35B51.27%655.89M17.82%3.46B
Other operating revenue ----3.51%7.92M-----40.96%3.3M-----27.15%7.65M----8.83%5.6M-----9.68%10.5M
Total operating cost -30.14%462.15M-17.18%3.15B-15.59%2.32B-9.79%1.53B27.85%661.54M44.85%3.81B76.83%2.75B72.20%1.69B62.05%517.42M37.38%2.63B
Operating cost -9.07%113.52M-1.95%597.56M3.88%451.26M-6.92%272.57M64.36%124.85M54.55%609.47M60.86%434.39M76.23%292.83M39.37%75.96M-1.37%394.34M
Operating tax surcharges -64.08%4.17M-3.68%32.03M1.09%25.37M50.32%19.71M134.35%11.62M67.71%33.25M96.91%25.1M60.98%13.11M53.10%4.96M14.10%19.83M
Operating expense -31.01%210.46M-24.85%1.52B-22.78%1.14B-13.33%783.05M18.70%305.03M51.93%2.02B94.64%1.48B80.97%903.5M63.57%256.98M17.77%1.33B
Administration expense 6.10%61.79M9.65%297.62M-2.72%180.63M6.17%120.9M6.59%58.23M-9.44%271.42M-8.10%185.68M-17.15%113.87M-9.89%54.63M36.54%299.71M
Financial expense 13.44%-14.8M-12.72%-70.99M1.10%-53.19M-10.75%-35.26M-20.32%-17.1M-62.65%-62.98M-105.73%-53.78M-98.79%-31.84M-83.26%-14.21M-26.14%-38.72M
-Interest expense (Financial expense) 164.41%3.38M-16.30%5.95M-31.83%3.76M-26.11%2.72M-57.67%1.28M23.15%7.11M38.49%5.51M58.42%3.69M211.10%3.02M865.92%5.77M
-Interest Income (Financial expense) -3.64%-18.31M-6.01%-74.23M-2.19%-52.66M-5.98%-36.26M-3.47%-17.67M-54.19%-70.03M-70.35%-51.53M-83.52%-34.21M-92.61%-17.08M-21.34%-45.42M
Research and development -51.36%87.02M-16.77%776.43M-15.34%573.44M-8.77%365.19M28.61%178.91M50.11%932.89M101.94%677.34M113.50%400.31M169.71%139.11M252.13%621.49M
Credit Impairment Loss -1,402.83%-9.89M-92.81%-88.52M-186,850.31%-67.08M-1,587.95%-60.68M-254.44%-658.31K-216.11%-45.91M99.76%-35.88K575.49%4.08M-91.08%426.26K-11.99%39.54M
Asset Impairment Loss -8.55%-7.61M-164.60%-162.64M57.44%-12.57M71.30%-3.59M-870.11%-7.01M-418.91%-61.47M-423.77%-29.54M-19.10%-12.51M78.89%-722.31K-140.82%-11.85M
Other net revenue -282.35%-77.95M-92.27%-347.59M54.69%-57.86M76.38%-9.47M193.47%42.75M-44.72%-180.78M-1,086.84%-127.72M-140.44%-40.1M-135.75%-45.74M-135.70%-124.92M
Fair value change income -7,010.23%-84.82M-17.77%-234.75M68.31%-67.39M75.39%-17.65M98.52%-1.19M29.00%-199.33M-125.78%-212.64M-511.82%-71.73M-181.58%-80.36M-200.30%-280.74M
Invest income 132.44%86.84K-39.69%7.11M30.18%6.29M1,266.22%6.33M-76.86%-267.7K-79.62%11.8M-91.68%4.84M-100.93%-542.64K72.95%-151.36K971.88%57.88M
-Including: Investment income associates 140.26%86.84K135.58%382.09K34.76%-437.76K25.55%-404.02K-42.50%-215.69K-15.18%-1.07M7.70%-670.98K-38.60%-542.64K72.95%-151.36K-615.85%-932.43K
Asset deal income -----116.55%-827.73K-1,703.04%-574.86K--172.21K--172.21K-265.55%-382.24K-116.58%-31.88K--------121.47%230.88K
Other revenue -53.05%24.28M15.30%132.03M-23.91%83.46M62.40%65.95M47.44%51.7M63.55%114.51M141.19%109.69M23.01%40.61M330.53%35.07M172.28%70.02M
Operating profit -72.19%59.65M-44.16%613.97M-6.00%779.31M2.58%632.06M131.30%214.48M54.79%1.1B47.10%829.07M32.11%616.16M-2.27%92.73M-48.39%710.28M
Add:Non operating Income -99.79%101.88619.41%935.06K1,413.66%933.18K1,242.62%913.18K231.12%48.85K-95.02%129.98K-97.13%61.65K-96.78%68.02K-99.16%14.75K-63.53%2.61M
Less:Non operating expense -36.87%2.4M-45.28%15.92M-74.18%6.02M-70.10%4.94M-58.74%3.8M638.26%29.1M694.08%23.33M452.91%16.54M318.56%9.2M-61.12%3.94M
Total profit -72.83%57.25M-44.05%598.98M-3.92%774.22M4.72%628.02M152.24%210.73M50.99%1.07B43.17%805.8M28.82%599.7M-11.54%83.54M-48.38%708.95M
Less:Income tax cost 52.41%18.94M-33.72%87.65M-34.25%76.99M-32.99%65.47M-26.00%12.43M22.91%132.24M49.40%117.1M68.46%97.7M-1.66%16.79M-33.63%107.59M
Net profit -80.68%38.31M-45.50%511.33M1.24%697.23M12.06%562.55M197.09%198.3M56.02%938.23M42.16%688.7M23.17%501.99M-13.72%66.75M-50.35%601.35M
Net profit from continuing operation -80.68%38.31M-45.50%511.33M1.24%697.23M12.06%562.55M197.09%198.3M56.02%938.23M42.16%688.7M23.17%501.99M-13.72%66.75M-50.35%601.35M
Less:Minority Profit -8.09%24.18M-56.13%91.93M-8.55%143.85M32.50%107.31M-6.45%26.31M20.72%209.57M31.00%157.31M-8.34%80.99M-37.78%28.13M-16.54%173.6M
Net profit of parent company owners -91.79%14.13M-42.44%419.39M4.14%553.38M8.13%455.24M345.34%171.99M70.35%728.65M45.84%531.39M31.90%421.01M20.09%38.62M-57.36%427.75M
Earning per share
Basic earning per share -91.81%0.0088-42.34%0.26212.40%0.34588.18%0.2844345.64%0.107466.70%0.454644.69%0.337728.37%0.262916.43%0.0241-58.16%0.2727
Diluted earning per share -91.81%0.0088-42.32%0.26212.49%0.34588.38%0.2844345.64%0.107467.12%0.454445.62%0.337430.16%0.262416.99%0.0241-57.74%0.2719
Other composite income -96.66%850K-86.67%25.45M
Other composite income of parent company owners ---------------------96.66%850K-------------86.67%25.45M
Total composite income -80.68%38.31M-45.55%511.33M1.24%697.23M12.06%562.55M197.09%198.3M49.82%939.08M42.16%688.7M23.17%501.99M-13.72%66.75M-55.29%626.8M
Total composite income of parent company owners -91.79%14.13M-42.51%419.39M4.14%553.38M8.13%455.24M345.34%171.99M60.97%729.5M45.84%531.39M31.90%421.01M20.09%38.62M-62.05%453.2M
Total composite income of minority owners -8.09%24.18M-56.13%91.93M-8.55%143.85M32.50%107.31M-6.45%26.31M20.72%209.57M31.00%157.31M-8.34%80.99M-37.78%28.13M-16.54%173.6M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg